This company has been marked as potentially delisted and may not be actively trading. (TMH) (TMH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock TMH vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, and CCRNShould you be buying (TMH) stock or one of its competitors? The main competitors of (TMH) include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry. (TMH) vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare (TMH) (NYSE:TMH) and Labcorp (NYSE:LH) are both health care services companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends. Which has higher earnings & valuation, TMH or LH? Labcorp has higher revenue and earnings than (TMH). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio(TMH)N/AN/AN/AN/AN/ALabcorp$13.18B1.55$746M$8.6528.18 Is TMH or LH more profitable? Labcorp has a net margin of 5.55% compared to (TMH)'s net margin of 0.00%. Labcorp's return on equity of 15.27% beat (TMH)'s return on equity.Company Net Margins Return on Equity Return on Assets (TMH)N/A N/A N/A Labcorp 5.55%15.27%6.97% Do analysts recommend TMH or LH? Labcorp has a consensus target price of $276.08, suggesting a potential upside of 13.27%. Given Labcorp's stronger consensus rating and higher probable upside, analysts plainly believe Labcorp is more favorable than (TMH).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score (TMH) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Labcorp 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.57 Do insiders & institutionals believe in TMH or LH? 95.9% of Labcorp shares are owned by institutional investors. 1.3% of (TMH) shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to TMH or LH? In the previous week, Labcorp had 17 more articles in the media than (TMH). MarketBeat recorded 17 mentions for Labcorp and 0 mentions for (TMH). Labcorp's average media sentiment score of 0.44 beat (TMH)'s score of 0.00 indicating that Labcorp is being referred to more favorably in the news media. Company Overall Sentiment (TMH) Neutral Labcorp Neutral SummaryLabcorp beats (TMH) on 10 of the 11 factors compared between the two stocks. Get (TMH) News Delivered to You Automatically Sign up to receive the latest news and ratings for TMH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMH vs. The Competition Export to ExcelMetric(TMH) Industry SectorNYSE ExchangeMarket CapN/A$2.02B$2.02B$20.74BDividend YieldN/A13.76%13.73%3.69%P/E RatioN/A12.5512.3227.56Price / SalesN/A2,735,822.492,818,684.6759.13Price / CashN/A20.1157.5222.13Price / BookN/A3.243.224.66Net IncomeN/A-$466.69M-$461.08M$994.58M (TMH) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMH(TMH)N/A$47.02+0.9%N/AN/A$0.00N/A0.00N/ALHLabcorp4.6165 of 5 stars$249.24-1.7%$276.38+10.9%+14.5%$21.23B$13.01B28.8170,000Upcoming EarningsAnalyst ForecastDGXQuest Diagnostics4.9498 of 5 stars$168.00-2.0%$185.73+10.6%+13.3%$19.14B$9.87B21.2456,000Upcoming EarningsAnalyst ForecastDVADaVita4.5085 of 5 stars$142.43-0.7%$164.50+15.5%+2.6%$10.83B$12.82B14.1276,000Positive NewsCHEChemed4.9828 of 5 stars$459.69-1.3%$645.00+40.3%-16.6%$6.81B$2.43B22.3915,695CRVLCorVel0.9786 of 5 stars$97.78-1.9%N/A+2.1%$5.13B$895.59M53.245,075News CoveragePositive NewsAMEDAmedisys2.9053 of 5 stars$97.18-0.5%$100.75+3.7%-0.3%$3.21B$2.35B35.8619,000News CoverageUpcoming EarningsMDPediatrix Medical Group3.0121 of 5 stars$13.13-2.7%$16.67+26.9%+64.7%$1.16B$2.01B-13.004,305Positive NewsAMNAMN Healthcare Services4.3472 of 5 stars$21.17-4.2%$32.08+51.6%-64.4%$846.09M$2.98B-4.892,968News CoveragePositive NewsAnalyst RevisionCCRNCross Country Healthcare3.6095 of 5 stars$12.07-3.1%$17.93+48.6%-18.6%$408.48M$1.34B-22.778,205News Coverage Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMH) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredSteve Jobs' Deathbed Secret Finally LeakedLeaked: Jobs’ Final Apple Project Exposed Bloomberg just leaked details of a secret project Steve Jobs set ...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (TMH) Please log in to your account or sign up in order to add this asset to your watchlist. Share (TMH) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.